ArticleBioMed research international2026
Prevalence and Predictors of Hepatitis B Virus Infection Among Sellers and Workers at West Africa's Largest Market, Kejetia, Ghana: A Cross-Sectional Study.
Article in BioMed research international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prevalence and Predictors of Hepatitis B Virus Infection Among Sellers and Workers at West Africa's Largest Market, Kejetia, Ghana: A Cross-Sectional Study.BioMed research international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHepatitis B virus (HBV) infection remains a major public health challenge in sub-Saharan Africa, including Ghana, despite the infant vaccination programs. Limited data exist on HBV prevalence and predictors in informal sector populations, who may face unique occupational and behavioral exposures. This study assessed the prevalence and predictors of HBV infection among sellers and workers at Kejetia Market, Ghana's largest commercial hub.
methodsA cross-sectional study was conducted among 489 adult market workers from December 4, 2024, to January 25, 2025. Participants were selected through stratified random sampling across occupational groups. Data on sociodemographic, occupational, and behavioral factors were collected using structured questionnaires. On-site testing for Hepatitis B surface antigen (HBsAg) was performed using the Hightop One Step Rapid Test kit. Bivariate and multivariate logistic regression analyses were used to identify independent predictors of HBV infection. p < 0.05 was considered statistically significant.
resultsThe overall prevalence of HBV infection was 7.36% (36/489), consistent with intermediate-to-high endemicity. Multivariate analysis identified three independent predictors of HBV infection. Female gender (aOR = 0.455, 95% CI: 0.221-0.937; p = 0.033) and absence of tattoos (aOR = 0.283, 95% CI: 0.110-0.730; p = 0.009) were associated with lower risk of HBV infection, whereas unvaccinated individuals had 3.37-fold increased odds of getting the infection (95% CI: 1.395-8.142; p = 0.007). HBV prevalence declined progressively with increasing vaccine doses, from 9.2% in unvaccinated individuals to 2.3% among those who had completed three or more doses.
conclusionHBV infection is common among Kejetia Market workers, with prevalence exceeding both continental and global estimates. Gender, tattooing, and vaccination status were significant predictors of infection. These findings highlight the urgent need for targeted adult Hepatitis B vaccination programs and strengthened occupational health interventions. They also emphasize the importance of regulating high-risk practices such as informal tattooing within Ghana's informal sector to reduce HBV burden and achieve Ghana's contribution to the WHO goal of eliminating HBV by 2030.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.